Harbor Capital Advisors, Inc. Atara Biotherapeutics, Inc. Transaction History

Harbor Capital Advisors, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 08, 2024	BUY	$0.23 - $1.74 $37,767 - $285,718	164,206 Added 368.0%	208,827 $106,000
Q3 2023 Oct 20, 2023	SELL	$1.41 - $2.31 $7,691 - $12,601	-5,455 Reduced 10.89%	44,621 $66,000
Q2 2023 Jul 11, 2023	BUY	$1.5 - $3.04 $75,114 - $152,231	50,076 New	50,076 $80,000

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.26B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Harbor Capital Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbor Capital Advisors, Inc. with notifications on news.